Myriad Genetics
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • Affordability
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
        • Documents & forms
        • Blood draw locator
        • Blog
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Scientific Publications
        • MyRisk® gene table
        • Affordability
        • Financial assistance
        • EMR Integrations
      • Provider resources
        • Order a test kit
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
        • Blood draw locator
        • Blog
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • FirstGene™
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise Tumor®
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
      • (column wrapper)
        • Newsroom
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Laboratory and Support Center
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640
PORTALS ORDER
    Portals
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • Affordability
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
        • Documents & forms
        • Blood draw locator
        • Blog
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Scientific Publications
        • MyRisk® gene table
        • Affordability
        • Financial assistance
        • EMR Integrations
      • Provider resources
        • Order a test kit
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
        • Blood draw locator
        • Blog
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • FirstGene™
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise Tumor®
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
      • (column wrapper)
        • Newsroom
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Laboratory and Support Center
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640

Myriad Genetics Blog

Myriad Genetics Blog
  • Category
    • All
    • About Myriad Genetics
    • Breast Cancer
    • Carrier screening
    • Colorectal Cancer
    • Corporate
    • Diversity
    • Employee Spotlight
    • EndoPredict
    • Equity
    • GeneSight
    • Genetic Counselors
    • Gynecologic Cancer
    • Hereditary Cancer
    • Inclusion
    • Infographic for Multimedia page
    • Infographics
    • Lynch Syndrome
    • Melanoma
    • Myriad Employees
    • Myriad Science and Facilities
    • MyRisk
    • Neuroscience
    • Oncology
    • Ovarian Cancer
    • Pancreatic Cancer
    • Patient Blog
    • Patient Story
    • Patient-Featured
    • Prenatal care
    • Prenatal Screening (NIPS)
    • Prequel
    • Prolaris
    • Prostate Cancer
    • Provider Blog
    • Uncategorized
    • Urology
    • Women's Health

Myriad Genetics 2019 Facts at a Glance

February 8, 2019

Myriad Genetics has been in business for more than 27 years and we are a global leader in personalized medicine.  Click on the image below to download our ...

Continue Reading

Myriad Women’s Health: Empowering women and their families to make critical and timely healthcare decisions

January 10, 2019

Counsyl, Inc. has combined with Myriad Genetics’ Preventive Care business unit to form Myriad Women’s Health, Inc., a premier genetic screening and personal...

Continue Reading

EndoPredict is the Only Test to Answer Three Critical Questions

December 7, 2018

EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can Forgo Extended Endocrine...

Continue Reading

Genetic Testing Helps Personalize Breast Cancer Treatment Decisions

October 1, 2018

According to the American Cancer Society, 1 in 8 U.S. women will be diagnosed with breast cancer in their lifetime.  In 2018, about 266,000 new cases of breast...

Continue Reading

Genetic Testing Can Help Men with Prostate Cancer Receive the Right Treatment

September 1, 2018

September is Prostate Cancer Awareness Month. According the American Cancer Society, more than 165,000 men will be diagnosed with prostate cancer this year, and...

Continue Reading

Helping to Realize the Benefits of Personalized Medicine for Minority Populations

July 2, 2018

The biomedical innovation now happening in the molecular diagnostics industry is making it possible for clinicians to answer their patients’ four most pressin...

Continue Reading

GeneSight: Helping Patients with Depression

May 15, 2018

Mental Health Month, Depression and GeneSight®   The GeneSight® genetic test has produced exciting news for patients diagnosed with depression.  A landmar...

Continue Reading

BRACAnalysis CDx Approved by FDA for Patients with HER2- Metastatic Breast Cancer

January 23, 2018

The U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® for use as a companion diagnostic to identify patients with HER2- metastatic breas...

Continue Reading

Winter Depression is a Serious Health Issue for Many People

January 17, 2018

It is estimated that 19 million people suffer from “year round” depression. If every American with depression lived in one state it would be the country’s...

Continue Reading

Andrea’s story: Cancer prevention can begin with knowing your family history

October 10, 2017

Shortly after I was born, my father was diagnosed with Hodgkin’s lymphoma and he passed away when he was just 29 years old.  Losing my dad when I was so youn...

Continue Reading

Men’s Health Month and Myriad’s Prolaris Test

June 12, 2017

June is Men’s Health Month and it’s important to help generate awareness on education for early detection of Men’s health issues, such as prostate cance...

Continue Reading
Advances in Genetics Testing for Cancer

Advances in Cancer Genetic Testing 2017 – ASCO

June 1, 2017 Continue Reading
Ronni Story GeneSight

GeneSight: Ronni’s Patient Story

May 15, 2017

“I just could not get out of bed, no matter how hard I tried.”   Years ago, before taking the GeneSight test, Ronni went through a very traumatic expe...

Continue Reading

GeneSight: A personalized approach to help patients get their lives back

May 2, 2017

What is GeneSight? [caption id="attachment_14843" align="alignright" width="400"] GeneSight Psychotropic[/caption] GeneSight Psychotropic is a laboratory devel...

Continue Reading
Extracting your own DNA

A Fun Experiment to Celebrate DNA Day!

April 25, 2017

Extract your own DNA at home! DNA, or Deoxyribonucleic acid, is the hereditary information in humans and most other plants and animals.  Nearly every cell in a...

Continue Reading
  • 1
  • 2
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 14
  • 15
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Newsroom
    • Blog
  • About
    • About Myriad
    • Careers
    • Contact us
  • Terms of Use
  • HIPAA Notice of Privacy Practices
  • Provider Portal Terms of Use
  • Privacy Notice
  • Patents
  • Health Privacy Notice
  • Compliance and Code of Conduct
  • Notice of Nondiscrimination and Discrimination Grievance Procedure
  • IT Security
  • Notice of Access to Language Assistance Services
  • Cookie Preferences
facebook linkedin x X/Twitter social network instagram youtube
  • © 2025 Myriad Genetics, Inc.

Locations

United States
Europe
Japan